NPFF1 receptor (npff1_human)
FAMILY
Class A (Rhodopsin) Peptide receptors Neuropeptide FF/neuropeptide AF receptors NPFF1 receptor
GENE
NPFFR1 (GPR147, NPFF1)
ORGANISM
Human (Homo sapiens)
ALT. NAMES
Neuropeptide FF receptor 1, G-protein coupled receptor 147, RFamide-related peptide receptor OT7T022
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
E
|
G
|
E
|
P
|
S
|
Q
|
P
|
P
|
N
|
10 |
S
|
S
|
W
|
P
|
L
|
S
|
Q
|
N
|
G
|
T
|
20 |
N
|
T
|
E
|
A
|
T
|
P
|
A
|
T
|
N
|
L
|
30 |
T
|
F
|
S
|
S
|
Y
|
Y
|
Q
|
H
|
T
|
S
|
40 |
TM1 | |||||||||
P
|
V
|
A
|
A
|
M
|
F
|
I
|
V
|
A
|
Y
|
50 |
A
|
L
|
I
|
F
|
L
|
L
|
C
|
M
|
V
|
G
|
60 |
N
|
T
|
L
|
V
|
C
|
F
|
I
|
V
|
L
|
K
|
70 |
ICL1 | TM2 | ||||||||
N
|
R
|
H
|
M
|
H
|
T
|
V
|
T
|
N
|
M
|
80 |
F
|
I
|
L
|
N
|
L
|
A
|
V
|
S
|
D
|
L
|
90 |
L
|
V
|
G
|
I
|
F
|
C
|
M
|
P
|
T
|
T
|
100 |
L
|
V
|
D
|
N
|
L
|
I
|
T
|
G
|
W
|
P
|
110 |
ECL1 | TM3 | ||||||||
F
|
D
|
N
|
A
|
T
|
C
|
K
|
M
|
S
|
G
|
120 |
L
|
V
|
Q
|
G
|
M
|
S
|
V
|
S
|
A
|
S
|
130 |
V
|
F
|
T
|
L
|
V
|
A
|
I
|
A
|
V
|
E
|
140 |
R
|
F
|
R
|
C
|
I
|
V
|
H
|
P
|
F
|
R
|
150 |
ICL2 | TM4 | ||||||||
E
|
K
|
L
|
T
|
L
|
R
|
K
|
A
|
L
|
V
|
160 |
T
|
I
|
A
|
V
|
I
|
W
|
A
|
L
|
A
|
L
|
170 |
L
|
I
|
M
|
C
|
P
|
S
|
A
|
V
|
T
|
L
|
180 |
ECL2 | |||||||||
T
|
V
|
T
|
R
|
E
|
E
|
H
|
H
|
F
|
M
|
190 |
V
|
D
|
A
|
R
|
N
|
R
|
S
|
Y
|
P
|
L
|
200 |
Y
|
S
|
C
|
W
|
E
|
A
|
W
|
P
|
E
|
K
|
210 |
TM5 | |||||||||
G
|
M
|
R
|
R
|
V
|
Y
|
T
|
T
|
V
|
L
|
220 |
F
|
S
|
H
|
I
|
Y
|
L
|
A
|
P
|
L
|
A
|
230 |
L
|
I
|
V
|
V
|
M
|
Y
|
A
|
R
|
I
|
A
|
240 |
R
|
K
|
L
|
C
|
Q
|
A
|
P
|
G
|
P
|
A
|
250 |
ICL3 | TM6 | ||||||||
P
|
G
|
G
|
E
|
E
|
A
|
A
|
D
|
P
|
R
|
260 |
A
|
S
|
R
|
R
|
R
|
A
|
R
|
V
|
V
|
H
|
270 |
M
|
L
|
V
|
M
|
V
|
A
|
L
|
F
|
F
|
T
|
280 |
L
|
S
|
W
|
L
|
P
|
L
|
W
|
A
|
L
|
L
|
290 |
ECL3 | |||||||||
L
|
L
|
I
|
D
|
Y
|
G
|
Q
|
L
|
S
|
A
|
300 |
TM7 | |||||||||
P
|
Q
|
L
|
H
|
L
|
V
|
T
|
V
|
Y
|
A
|
310 |
F
|
P
|
F
|
A
|
H
|
W
|
L
|
A
|
F
|
F
|
320 |
N
|
S
|
S
|
A
|
N
|
P
|
I
|
I
|
Y
|
G
|
330 |
H8 | |||||||||
Y
|
F
|
N
|
E
|
N
|
F
|
R
|
R
|
G
|
F
|
340 |
Q
|
A
|
A
|
F
|
R
|
A
|
R
|
L
|
C
|
P
|
350 |
C-term | |||||||||
R
|
P
|
S
|
G
|
S
|
H
|
K
|
E
|
A
|
Y
|
360 |
S
|
E
|
R
|
P
|
G
|
G
|
L
|
L
|
H
|
R
|
370 |
R
|
V
|
F
|
V
|
V
|
V
|
R
|
P
|
S
|
D
|
380 |
S
|
G
|
L
|
P
|
S
|
E
|
S
|
G
|
P
|
S
|
390 |
S
|
G
|
A
|
P
|
R
|
P
|
G
|
R
|
L
|
P
|
400 |
L
|
R
|
N
|
G
|
R
|
V
|
A
|
H
|
H
|
G
|
410 |
L
|
P
|
R
|
E
|
G
|
P
|
G
|
C
|
S
|
H
|
420 |
L
|
P
|
L
|
T
|
I
|
P
|
A
|
W
|
D
|
I
|
430 |
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
RFRP-3, RFRP-1, QRFP43 (43RFa), neuropeptide SF, PrRP-31, neuropeptide AF, neuropeptide FF
STRUCTURE MODELS
STRUCTURES
No structures available